ReviewCancers2023

Neoadjuvant Immune Checkpoint Inhibitors for Resectable Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis.

Mei Zhao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.